Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bivalent Ligand
100%
Heteromer
76%
Indole
58%
Metabotropic Glutamate Receptor 5 (mGluR5)
53%
Morphine
48%
Antinociception
44%
Opioids
43%
Neuropathic Pain
42%
Pharmacophore
41%
Analgesic
38%
μ-opioid Receptor
37%
Hyperalgesia
36%
Opioid Receptors
31%
Acid-catalyzed
29%
ED50
26%
Inflammatory Pain
25%
Cholecystokinin Receptor
23%
Phenazone
23%
Reaction Synthesis
23%
Nociception
23%
PET Imaging Agent
23%
δ Opioid Receptor
23%
Cisplatin
23%
Staudinger Reaction
23%
Method Analysis
23%
Elemental Analysis
23%
Methane
23%
Heterocycles
23%
Spectroscopic Techniques
23%
Beta-lactams
23%
CCK2 Receptor
22%
Opioid Antagonist
22%
C-C Chemokine Receptor Type 5 (CCR5)
22%
Aryl
21%
Co-agonist
20%
Synthetic Opioids
19%
Condensation
17%
Mouse Model
17%
Orthoester
17%
Ethene
17%
Lithium
17%
Acylation
17%
Pyrazolyl
17%
Triethylborane
17%
Monovalent Cations
17%
Intrathecal
16%
Bone Cancer
15%
Pyrazoline
15%
Cyanine Dyes
15%
Cholecystokinin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Heteromer
76%
Receptor
73%
Morphine
47%
Neuropathic Pain
42%
Analgesic Agent
38%
μ-Opioid Receptor
37%
Hyperalgesia
36%
Antinociception
32%
Inflammatory Pain
28%
Bone Cancer
28%
Cholecystokinin B Receptor
26%
Metabotropic Receptor 5
26%
Cholecystokinin A Receptor
23%
Intrathecal
23%
Cisplatin
23%
Cholecystokinin
23%
Opiate Receptor
21%
Mouse Model
20%
Opiate Agonist
19%
Mu Opiate Receptor Agonist
18%
Chronic Pain
17%
Cancer Pain
17%
Binding Site
16%
Inflammation
15%
Chemokine Receptor
13%
Lipopolysaccharide
12%
Phenazone
11%
Cholecystokinin Receptor
11%
Potassium Acetate
11%
Chemokine
11%
Loperamide
11%
Sickle Cell Anemia
11%
Iodine 124
11%
Rheumatoid Arthritis
11%
Delta Opiate Receptor
11%
Cannabinoid 1 Receptor
11%
Oxymorphone
11%
Cancer Model
11%
Benzodiazepine Receptor Blocking Agent
11%
Polyethylene Terephthalate
11%
Inflammatory Arthritis
11%
Nerve Injury
11%
Pyrazoline
11%
Carbonyl Derivative
11%
Arthritis
11%
Adverse Event
10%
Neoplasm
9%
Oxymorphindole
9%
Chemotherapy-Induced Peripheral Neuropathy
8%
Mechanical Hyperalgesia
8%